Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial (Q45006027)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial
scientific article

    Statements

    Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial (English)
    Matthew R Smith
    Mary Anne Fallon
    Joel S Finkelstein
    1 August 2004
    3841-3846

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit